✦ LIBER ✦

Development of appropriate equations for physiologically based pharmacokinetic modeling of permeability-limited and flow-limited transport

✍ Scribed by Matthew D. Thompson; Daniel A. Beard

Publisher: Springer
Year: 2011
Tongue: English
Weight: 504 KB
Volume: 38
Category: Article
ISSN: 1573-8744
DOI: 10.1007/s10928-011-9200-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Asymptotic solutions and limits of trans

Asymptotic solutions and limits of transport equations for tubular flow photoreactors

✍ John A. Williams; Francis P. Ragonese 📂 Article 📅 1970 🏛 Elsevier Science 🌐 English ⚖ 684 KB

Development and validation of limited sa

Development and validation of limited sampling models for topotecan lactone pharmacokinetic studies in children

✍ P. Kellie Turner; Lisa C. Iacono; John C. Panetta; Victor M. Santana; Najat C. D 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 338 KB

Development of a pharmacokinetic limited

Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC

✍ Mark N. Kirstein; John C. Panetta; Amar Gajjar; Geeta Nair; Lisa C. Iacono; Burg 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 300 KB

Development and application of a general

Development and application of a generalized physiologically based pharmacokinetic model for multiple environmental contaminants

✍ Thomas M. Cahill; Ian Cousins; Donald Mackay 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Feasibility of using limited-population-

Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data

✍ Ya Wang; Wei Huang; David M. Panicek; Lawrence H. Schwartz; Jason A. Koutcher 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

## Abstract For clinical dynamic contrast‐enhanced (DCE) MRI studies, it is often not possible to obtain reliable arterial input function (AIF) in each measurement. Thus, it is important to find a representative AIF for pharmacokinetic modeling of DCE‐MRI data when individual AIF (Ind‐AIF) measurem

Development of a human physiologically b

Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites

✍ Hisham A. El-Masri; Elaina M. Kenyon 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 726 KB